Patel et al. [16] suggested that TET2, ASXL1, and SRSF2 were ancestral mutations present in early stages of CMML and that KRAS, NRAS, RUNX1, U2AF1, and CBL mutations were secondary events leading to AML transformation. The gene discussed is SRSF2; the disease is acute myeloid leukemia.